Results 181 to 190 of about 9,644 (307)

Essential Oils and Plant Extracts for Postharvest Control of Monilinia fructicola in Peaches: Direct Antifungal Activity and Defence Induction

open access: yesJournal of Phytopathology, Volume 174, Issue 1, January/February 2026.
ABSTRACT This study evaluated the antifungal potential of essential oils and plant extracts for the control of Monilinia fructicola, the causal agent of brown rot in peaches, under in vitro and postharvest conditions. Essential oils and cold aqueous, hot aqueous, and hydroalcoholic extracts of Allium sativum, Syzygium aromaticum, Origanum vulgare ...
Ediane Roncaglio Baseggio   +4 more
wiley   +1 more source

Emergency Alcohol Septal Ablation for Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy. [PDF]

open access: yesJACC Case Rep
Arman HE   +7 more
europepmc   +1 more source

Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. [PDF]

open access: yesCirc Cardiovasc Interv, 2023
Alabdaljabar MS   +6 more
europepmc   +1 more source

Antenatal melatonin for cardiovascular deficits in fetal growth restriction

open access: yesThe Journal of Physiology, Volume 604, Issue 1, Page 193-213, 1 January 2026.
Abstract figure legend This study used an ovine model of fetal growth restriction (FGR) to investigate the potential cardioprotective effects of melatonin (MLT) in postnatal growth‐restricted lambs. We demonstrated that, while peripheral endothelial function progressively declines between birth and 4 weeks in FGR lambs, FGR+MLT lambs exhibit impaired ...
Charmaine R. Rock   +9 more
wiley   +1 more source

Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy. [PDF]

open access: yesJ Am Heart Assoc
Dybro AM   +8 more
europepmc   +1 more source

Low‐Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real‐World Study in China

open access: yesCardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Aims To evaluate the real‐world efficacy and safety of low‐dose (2.5 mg) mavacamten initiation in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Methods and Results This single‐center observational study (Zhongshan Hospital, China; Oct 2024–Apr 2025) enrolled 72 symptomatic oHCM patients (NYHA II/III, LVEF ≥ 55 ...
Wenlong Yang   +9 more
wiley   +1 more source

Alcohol septal ablation therapy for HOCM patients

open access: yesIndian Heart Journal, 2015
B. Jai Bharat   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy